Publications

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial

Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90

Investigating secondary use of clinical research data: a protocol for a mixed methods study (Preprint)

Waithira N. et al, (2022), JMIR Research Protocols

Understanding the extent and impact of secondary use of clinical research data with a focus on Low and Middle Income Countries: a cross sectional mixed methods study (REUSE) (Preprint)

Waithira N. et al, (2022)

Correction: Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial.

Mshamu S. et al, (2022), Trials, 23

Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial.

Mshamu S. et al, (2022), Trials, 23

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878

Community seroprevalence and risk factors for SARS-CoV-2 infection in different subpopulations in Vellore, India, and their implications for future prevention.

Dayanand D. et al, (2022), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 116, 138 - 146

Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study.

Patson N. et al, (2022), BMC medical research methodology, 22

Contribution of genetic factors to high rates of neonatal hyperbilirubinaemia on the Thailand-Myanmar border.

Bancone G. et al, (2022), PLOS Glob Public Health, 2

Effect of adverse events on non-adherence and study non-completion in malaria chemoprevention during pregnancy trial: A nested case control study.

Patson N. et al, (2022), PloS one, 17

Effect of patient-delivered household contact tracing and prevention for tuberculosis: A household cluster-randomised trial in Malawi.

Kaswaswa K. et al, (2022), PloS one, 17

Under the Mask: A Film on Tuberculosis at the Thai-Myanmar Border.

Delmas MV. et al, (2022), Frontiers in public health, 10

Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection

Mukaka M. et al, (2021), Malaria Journal, 20

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria

Taylor WR. et al, (2021), Malaria Journal, 20

Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion

Imwong M. et al, (2021), Antimicrobial Agents and Chemotherapy, 65

Addressing the statistical analysis dilemma that exists when analyzing clinical trial results with full efficacy using the Kaplan Meier survival analysis method

Peerawaranun P. et al, (2021), Experimental Results, 2

Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial.

Patson N. et al, (2021), BMC medical research methodology, 21

High levels of pathological jaundice in the first 24 hours and neonatal hyperbilirubinaemia in an epidemiological cohort study on the Thailand-Myanmar border

Thielemans L. et al, (2021), PLOS ONE, 16, e0258127 - e0258127

Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.

Hamaluba M. et al, (2021), The Lancet. Infectious diseases, 21, 1395 - 1406

Cookies on this website

Publications